ASU study shows 1st promising links between active ingredient capsaicinoids and an individual’s energy-burning abilityContinue reading
Category Archives: AZBio News
FDA Grants “Fast Track” Status to Cancer Prevention Pharmaceuticals’ Lead Drug CPP-1X/sul for Treatment of Familial Adenomatous Polyposis
CPP-1X/sul aims to prevent disease progression in patients with Familial Adenomatous Polyposis
Mark W. Mitchell, Mayor of the City of Tempe Arizona, to be honored with the AZBio Public Service Award at the 2017 AZBio Awards
The Arizona Bioindustry Association will honor Mark W. Mitchell, Mayor of the City of Tempe Arizona, with the AZBio Public Service Award at the 2017 AZBio Awards. Arizona life science and business leaders as well as guests from across the country will be on hand to applaud Mayor Mitchell for his leadership and support of Tempe’s growing life science industry.Continue reading
SalutarisMD Featured on MetroWeek
SalutarisMD is developing a minimally invasive ophthalmic technology for the treatment of Wet AMD. The technology delivers a single dose of brachytherapy.
Continue reading
Arizona Alzheimer’s collaboration lands $5M grant
The research project is a collaborative effort between the Banner Alzheimer’s Institute, Banner Sun Health Research Institute, the Translational Genomics Research Institute (TGen), the Arizona State University-Banner Neurodegenerative Disease Research Center at the Biodesign Institute, and the Arizona Alzheimer’s Consortium. It also includes researchers from the Icahn School of Medicine at Mount Sinai.Continue reading
Students Use CyVerse to Help Predict Mosquito-Borne Diseases
A UA course employed the CyVerse computational resource to develop the proof of concept for a map that predicts the abundance of mosquitoes transmitting diseases such as Zika virus and Dengue fever across the U.S.Continue reading
BIO 2018 Call For Sessions & Speakers
This is a great opportunity to show the world what great thought leaders we have in Arizona!Continue reading
Axolotl Biologix Launches AxoBioFluid A™ an Ambient Temperature Amnion-Derived Allograft Fluid
Axolotl Biologix, an innovator in regenerative medicine technologies that improve patient outcomes with less pain and lower costs, announced that it will begin shipping its third amniotic allograft product, AxoBioFluid® A on October 1st of this year.Continue reading